Breast Cancer: St. Gallen Meeting Endorses Multi-Gene Assays for Refining Chemo Decision

Published: July 21, 2009, 6:41 p.m.

b'

Also from the Palm Beach Cancer Symposium, Kathy Albain, MD, talks about the St. Gallen consensus meeting\\u2019s updated recommendations about adjuvant therapy for breast cancer\\u2014i.e., endorsing the 21-gene recurrence score and 70-gene profiling assay as key tools in decision-making for chemotherapy for ER-positive disease.

'